<DOC>
	<DOCNO>NCT00085813</DOCNO>
	<brief_summary>This study design determine effective safe Ispinesib treat locally advanced metastatic Non-small Cell Lung cancer patient receive platinum-based chemotherapy whose disease continue progress . Treatment involve 1-hr treatment give intravenously ( IV ) , repeat every 21 day . A patient may continue treatment long benefiting treatment . Blood sample take specific time 24 hr period measure amount drug body specific time drug give . Blood sample also take routine lab test complete blood count clinical chemistry . Physical exam perform treatment .</brief_summary>
	<brief_title>Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Must receive one prior platinumbased chemotherapy regimen . Blood test do check blood count adequate take part study . Received 1 chemotherapy regimen past less adequate liver kidney function . Females pregnant . Any unstable , preexist major medical condition history cancer . Have receive investigational drug , chemotherapy , radiation treatment surgery within 28 day prior enter study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Platinum-Refractory</keyword>
	<keyword>Platinum-Relapsed</keyword>
	<keyword>Non-Small Cell Lung Cancer</keyword>
</DOC>